Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathews

Showing results (471-480 of 474) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 474 results.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2020
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritisChenzhi Jing, Tomas Castro-Dopico, Nathan Richoz, et al.
Nature Medicine|September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's diseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Pageof 48

Showing results (471-480 of 474) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 474 results.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2020
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritisChenzhi Jing, Tomas Castro-Dopico, Nathan Richoz, et al.
Nature Medicine|September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's diseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Pageof 48